Evidence map›Paper›PMID 37574805›Full record

ArticleProtein science : a publication of the Protein Society2023

Engineering the catalytic activity of an Antarctic PET-degrading enzyme by loop exchange.

Paula Blázquez-Sánchez, Jhon A Vargas, Adriano A Furtado, Aransa Griñen, Diego A Leonardo, Susana A Sculaccio, Humberto D'Muniz Pereira, Christian Sonnendecker, Wolfgang Zimmermann, Beatriz Díez and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Engineering the catalytic activity of an Antarctic PET-degrading enzyme by loop exchange.Protein science : a publication of the Protein Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Paula Blázquez-SánchezInstitute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0003-3232-909X
Jhon A VargasSão Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil.ORCID 0000-0002-4946-1807
Adriano A FurtadoSão Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil.ORCID 0009-0009-7565-3413
Aransa GriñenInstitute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Diego A LeonardoSão Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil.ORCID 0000-0003-4264-3074
Susana A SculaccioSão Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil.ORCID 0009-0008-1495-4813
Humberto D'Muniz PereiraSão Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil.ORCID 0000-0002-8652-6729
Christian SonnendeckerInstitute of Analytical Chemistry, Leipzig University, Leipzig, Germany.ORCID 0000-0001-7904-7343
Wolfgang ZimmermannInstitute of Analytical Chemistry, Leipzig University, Leipzig, Germany.ORCID 0000-0002-5730-6663
Beatriz DíezDepartment of Molecular Genetics and Microbiology, School of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0002-9371-8083
Richard C GarrattSão Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil.ORCID 0000-0002-2016-3179
César A Ramírez-SarmientoInstitute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0003-4647-903X
Universidade Federal de São Carlos · BRPontificia Universidad Católica de Chile · CLLeipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several hydrolases have been described to degrade polyethylene terephthalate (PET) at moderate temperatures ranging from 25°C to 40°C. These mesophilic PET hydrolases (PETases) are less efficient in degrading this plastic polymer than their thermophilic homologs and have, therefore, been the subject of many protein engineering campaigns. However, enhancing their enzymatic activity through rational design or directed evolution poses a formidable challenge due to the need for exploring a large number of mutations. Additionally, evaluating the improvements in both activity and stability requires screening numerous variants, either individually or using high-throughput screening methods. Here, we utilize instead the design of chimeras as a protein engineering strategy to increase the activity and stability of Mors1, an Antarctic PETase active at 25°C. First, we obtained the crystal structure of Mors1 at 1.6 Å resolution, which we used as a scaffold for structure- and sequence-based chimeric design. Then, we designed a Mors1 chimera via loop exchange of a highly divergent active site loop from the thermophilic leaf-branch compost cutinase (LCC) into the equivalent region in Mors1. After restitution of an active site disulfide bond into this chimera, the enzyme exhibited a shift in optimal temperature for activity to 45°C and an increase in fivefold in PET hydrolysis when compared with wild-type Mors1 at 25°C. Our results serve as a proof of concept of the utility of chimeric design to further improve the activity and stability of PETases active at moderate temperatures.

Indexed as

HydrolasesPolyethylene TerephthalatesAntarctic RegionsHydrolysisPlasticsProtein EngineeringHydrolasesPlasticsPolyethylene Terephthalatesmesophilic enzymesPET hydrolasesplasticspolyethylene terephthalateprotein engineering

Identifiers

PMID37574805
PMCPMC10464292
OpenAlexW4385798704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.